Actar is a drug discovery company based on the Karolinska Institutet campus and
is a part of the Karolinska Institutet´s innovation system. Actar explores
innovative drug targets in multiple therapeutic areas resulting from academic
research and collaborates with the academic researchers to perform drug
discovery based on these targets. Drug-like compounds active against targets are
identified, characterized and divested, or further developed in collaboration
with larger pharmaceutical companies. Presently, Actar is performing discovery
research in four therapeutic areas: oncology, neuroscience, inflammation and
angiogenesis. Actar was founded in 2000 and is privately owned.
Members
Areas
|
Actar ABFogdevreten 2 BSE-171 77, SolnaSwedenPhone: +46 8 524 84801Fax: +46 8 524 84 800URL: Webpage |